In situ studies of catecholamine-induced lipolysis in human adipose tissue using microdialysis

P Arner, E Kriegholm and P Engfeldt

Department of Medicine, Huddinge Hospital, Sweden.

The effects of catecholamines on lipolysis in situ were investigated in humans. Subcutaneous adipose tissue was microdialyzed with solvents containing adrenergic agents. Norepinephrine caused a rapid increase in the glycerol level in adipose tissue (lipolysis index) that was further increased by the alpha adrenoreceptor blocker phentolamine. At 10(-11) mol/l of norepinephrine caused a 100% stimulation of lipolysis (P less than .025). In the presence of phentolamine the lipolytic effects of catecholamines at 10(-12) mol/l was isoproterenol greater than epinephrine greater than norepinephrine. All these three lipolytic catecholamines caused a transient increase in the adipose tissue dialysate glycerol level, which peaked after 20 to 30 min of catecholamine exposure and then declined. The apparent tachyphylaxia could not be overcome by a gradual increase of the catecholamine concentration from 10(-12) to 10(-8) mol/l. However, the selective alpha-2 adrenoreceptor agonist clonidine caused a continuous and dose- dependent decrease in the dialysate glycerol level; the minimum effective concentration was 10(-9) mol/l. In conclusion, catecholamines have a lipolytic effect in situ at much lower concentrations than those in the circulation. This effect is transient and is related to beta adrenoreceptors. In additio, catecholamines have alpha adrenoreceptor- mediated effects on lipolysis in situ.

Volume 254, Issue 1, pp. 284-288, 07/01/1990
Copyright © 1990 by American Society for Pharmacology and Experimental Therapeutics

This article has been cited by other articles:

				R. B.M. Hosein, K. P. Morris, W. J. Brawn, and D. J. Barron Use of tissue microdialysis to investigate hyperlactataemia following paediatric cardiac surgery Interactive CardioVascular and Thoracic Surgery, June 1, 2008; 7(3): 384 - 388. [Abstract] [Full Text] [PDF]

				C. Moro, F. Pillard, I. de Glisezinski, F. Crampes, C. Thalamas, I. Harant, M.-A. Marques, M. Lafontan, and M. Berlan Atrial natriuretic peptide contribution to lipid mobilization and utilization during head-down bed rest in humans Am J Physiol Regulatory Integrative Comp Physiol, August 1, 2007; 293(2): R612 - R617. [Abstract] [Full Text] [PDF]

				C. Moro, J. Polak, J. Hejnova, E. Klimcakova, F. Crampes, V. Stich, M. Lafontan, and M. Berlan Atrial natriuretic peptide stimulates lipid mobilization during repeated bouts of endurance exercise Am J Physiol Endocrinol Metab, May 1, 2006; 290(5): E864 - E869. [Abstract] [Full Text] [PDF]

				P English and G Williams Hyperglycaemic crises and lactic acidosis in diabetes mellitus Postgrad. Med. J., May 1, 2004; 80(943): 253 - 261. [Abstract] [Full Text] [PDF]

				V. Stich, T. Pelikanova, P. Wohl, C. Sengenes, A. Zakaroff-Girard, M. Lafontan, and M. Berlan Activation of {alpha}2-adrenergic receptors blunts epinephrine-induced lipolysis in subcutaneous adipose tissue during a hyperinsulinemic euglycemic clamp in men Am J Physiol Endocrinol Metab, September 1, 2003; 285(3): E599 - E607. [Abstract] [Full Text] [PDF]

				M. Flechtner-Mors, C. P. Jenkinson, A. Alt, G. Adler, and H. H. Ditschuneit In Vivo alpha 1-Adrenergic Lipolytic Activity in Subcutaneous Adipose Tissue of Obese Subjects J. Pharmacol. Exp. Ther., April 1, 2002; 301(1): 229 - 233. [Abstract] [Full Text] [PDF]

				E. Hagstrom-Toft, S. Enoksson, E. Moberg, J. Bolinder, and P. Arner beta -Adrenergic regulation of lipolysis and blood flow in human skeletal muscle in vivo Am J Physiol Endocrinol Metab, December 1, 1998; 275(6): E909 - E916. [Abstract] [Full Text] [PDF]

				L. K. M. Summers, P. Arner, V. Ilic, M. L. Clark, S. M. Humphreys, and K. N. Frayn Adipose tissue metabolism in the postprandial period: microdialysis and arteriovenous techniques compared Am J Physiol Endocrinol Metab, April 1, 1998; 274(4): E651 - E655. [Abstract] [Full Text] [PDF]